Treatment of Advanced NSCLC Patients with an Anti-Idiotypic NeuGcGM3-Based Vaccine : Immune Correlates in Long-Term Survivors
Contributors
Mazorra, Zaima; Cáceres-Lavernia, Haslen H; Nenínger-Vinageras, Elia; Varona-Rodríguez, Leslie M; Viada, Carmen Elena; González, Zuyen; Rodríguez-Zhurbenko, Nely; Thierry, Anne-Christine; Suarez-Formigo, Gisela María; Ventura-Carmenate, YendryPublished in
Biomedicines, vol. 13, no. 5, 1122Publication date
2025-05-06First online date
2025-05-06Abstract
Keywords
- Anti-idiotypic cancer vaccine
- Circulating biomarkers
- Non-small cell lung cancer
UNIGE research groups
Citation (ISO format)
MAZORRA, Zaima et al. Treatment of Advanced NSCLC Patients with an Anti-Idiotypic NeuGcGM3-Based Vaccine : Immune Correlates in Long-Term Survivors. In: Biomedicines, 2025, vol. 13, n° 5, p. 1122. doi: 10.3390/biomedicines13051122
Main files (1)
Article (Published version)
Secondary files (1)
Appendix
Identifiers
- PID : unige:186019
- DOI : 10.3390/biomedicines13051122
- PMID : 40426949
- PMCID : PMC12109512
